Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 4 | 2024 | 1565 | 0.290 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2017 | 34 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 592 | 0.280 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2017 | 150 | 0.270 |
Why?
|
| Pyridones | 2 | 2024 | 51 | 0.240 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2022 | 11 | 0.210 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 154 | 0.190 |
Why?
|
| Cell Cycle Proteins | 3 | 2024 | 388 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 2903 | 0.180 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 696 | 0.170 |
Why?
|
| Piperazines | 1 | 2020 | 272 | 0.160 |
Why?
|
| Pyridines | 1 | 2020 | 310 | 0.160 |
Why?
|
| Thiophenes | 1 | 2017 | 48 | 0.150 |
Why?
|
| Proteins | 1 | 2022 | 777 | 0.140 |
Why?
|
| Apoptosis | 2 | 2013 | 1683 | 0.130 |
Why?
|
| Breast | 1 | 2017 | 288 | 0.130 |
Why?
|
| Tamoxifen | 1 | 2015 | 168 | 0.130 |
Why?
|
| Models, Molecular | 4 | 2022 | 1286 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2022 | 458 | 0.120 |
Why?
|
| S Phase | 1 | 2013 | 62 | 0.110 |
Why?
|
| G1 Phase | 1 | 2013 | 63 | 0.110 |
Why?
|
| Retinoblastoma Protein | 1 | 2013 | 66 | 0.110 |
Why?
|
| Protein Domains | 2 | 2024 | 128 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2013 | 227 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2426 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2013 | 271 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 2360 | 0.090 |
Why?
|
| Ginsenosides | 1 | 2010 | 123 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 381 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2022 | 408 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2013 | 488 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 384 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2022 | 96 | 0.050 |
Why?
|
| Animals | 5 | 2022 | 26590 | 0.050 |
Why?
|
| Mice | 3 | 2022 | 11356 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2022 | 303 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2024 | 339 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2022 | 287 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 159 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 106 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2020 | 290 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 861 | 0.040 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2017 | 40 | 0.040 |
Why?
|
| Drug Design | 1 | 2015 | 124 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2231 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 790 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 144 | 0.030 |
Why?
|
| Uterus | 1 | 2015 | 215 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 1921 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 67 | 0.030 |
Why?
|
| Humans | 5 | 2022 | 86678 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2013 | 209 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 33 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 53 | 0.020 |
Why?
|
| Vacuoles | 1 | 2010 | 46 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 59 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2010 | 151 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 67 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 155 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 256 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 199 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 7998 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 782 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 615 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 969 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 599 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 480 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 445 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1961 | 0.020 |
Why?
|
| Female | 2 | 2017 | 44550 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 938 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3243 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 3968 | 0.010 |
Why?
|